Please login to the form below

Hal Barron

This page shows the latest Hal Barron news and features for those working in and with pharma, biotech and healthcare.

GSK hires Merck KGaA exec to lead US pharma business

On the surface, his replacement is a good fit for the new direction GSK is taking under the leadership of CEO Emma Walmsley and CSO Hal Barron. ... At GSK, Martinez-Davis will oversee US pharmaceuticals across all diseases but, if pipeline programmes

Latest news

Hal Barron touts new drive to improve GSK’s research output

'Consensus-led' research being replaced with bold decision-making. GlaxoSmithKline’s research and development leader Dr Hal Barron says he has swept away a longstanding consensus-led and risk-averse approach ... Hal Barron. “We’re all human, so if
GSK pushes rheumatoid arthritis antibody into phase 3

Since then, GSK has appointed heavy hitter Hal Barron as its R&D chief, fleshed out its pipeline with the acquisition of Tesaro, renewed a push into oncology, and cut 30%
GSK joins forces with Doudna’s CRISPR lab

New recruit Chris Miller will head GSK's functional genomics push. GlaxoSmithKline’s research chief Hal Barron is deepening its investment in cutting-edge science via a new CRISPR gene-editing ... Dr Barron said: “Technology is key to our innovation
GSK’s myeloma drug hits target, prompting rapid filing pledge

GSK says the results show efficacy, durability and depth of response, and Hal Barron says the drug could be ready to submit to regulators by the end of 2019. ... GSK's Hal Barron. “These data are very encouraging and I am excited by what they could
Advair generics and acquisitions to hit GSK in 2019

Emma Walmsley: major changes across the business in 2019. Chief executive Emma Walmsley continues to highlight the firm’s R&D rebuilding, led by new research leader Hal Barron, with 33

More from news
Approximately 1 fully matching, plus 43 partially matching documents found.

Latest Intelligence

30 Women Leaders in UK Healthcare (part 3)

Walmsley has impressed with a few high-profile hirings to key positions, including Dr Hal Barron as its new R&D supremo, but it will take a few years to see

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Kevin Sin joins GSK

years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said: “I am extremely excited to have Kevin join GSK. ... Sin will report to Hal Barron and will be based at the group’s San Francisco office.
Levinson resigns from Roche board

He has served as CEO at Calico, Google's health research business, since its formation in September 2013 and has since been joined by former Genentech/Roche colleagues Hal Barron, David
Roche CMO joins Google health venture Calico

Hal Barron among four new appointments. Dr Hal Barron has left his role as chief medical officer of Swiss pharma company Roche to join Google's recently-launched health research arm ... Dr Barron is one of four new recruits from industry and academia to

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director – UK Office: Excellent salary and benefits

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Account Director, Healthcare Communications: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...